Zimmer Biomet Holdings, Inc. Earnings Dividend

Zimmer Biomet Holdings, Inc.’s revenue jumped 9.3% since last year same period to $2086.7Mn in the Q1 2026. On a quarterly growth basis, Zimmer Biomet Holdings, Inc. has generated -7% fall in its revenue since last 3-months.

Zimmer Biomet Holdings, Inc.’s net profit jumped 30.82% since last year same period to $238.1Mn in the Q1 2026. On a quarterly growth basis, Zimmer Biomet Holdings, Inc. has generated 70.68% jump in its net profits since last 3-months.

Zimmer Biomet Holdings, Inc.’s net profit margin jumped 19.69% since last year same period to 11.41% in the Q1 2026. On a quarterly growth basis, Zimmer Biomet Holdings, Inc. has generated 83.53% jump in its net profit margins since last 3-months.

Zimmer Biomet Holdings, Inc.’s price-to-earnings ratio after this Q1 2026 earnings stands at 21.54.

Zimmer Biomet Holdings, Inc.’s earning per share (EPS) estimates for the current quarter stand at 1.86 - a -22.32% fall from last quarter’s estimates.

Zimmer Biomet Holdings, Inc.’s earning per share (EPS) estimates for the current year stand at 1.86.

Zimmer Biomet Holdings, Inc.’s earning per share (EPS) jumped 15.47% since last year same period to 2.09 in the Q1 2026. This indicates that the Zimmer Biomet Holdings, Inc. has generated 15.47% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Zimmer Biomet Holdings, Inc.’s return on assets (ROA) stands at 0.04.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Zimmer Biomet Holdings, Inc.’s return on equity (ROE) stands at 0.06.

Zimmer Biomet Holdings, Inc. declared 0.24 dividend per share during the earnings announcement for Q1 2026.